Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Titan Biotech Ltd

Your Vote -

Buy

52.00%

Hold

20.00%

Sell

28.00%

52.00%

25 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Titan Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Titan Biotech Q4 net profit down 22.11% at Rs 3.77 cr

    30 May 2025, 5:45PM The company reported standalone net profit of Rs 3.77 crore for the quarter ended March 31, 2025 as compared to Rs 4.84 crore in the same period last
  • Titan Biotech Ltd. - Corporate Action-Board to consider Dividend

    30 May 2025, 4:45PM The Board of Directors of Company have recommended a dividend of Rs. 2.00 per equity share
  • Titan Biotech Ltd. - Appointment Of Internal Auditor

    30 May 2025, 4:41PM Intimation for appointment of Internal Auditor
  • Titan Biotech Ltd. - Appointment Of Cost Auditor

    30 May 2025, 4:40PM Appointment of Cost Auditor
  • Titan Biotech Ltd. - Appointment Of Secretarial Auditor

    30 May 2025, 4:38PM Appointment of Secretarial Auditor
  • Titan Biotech Ltd. - Results_Audited Financial Results For The Quarter And Year Ended March 31, 2025

    30 May 2025, 4:32PM Audited Financial Results_March 31, 2025
  • Titan Biotech Ltd. - Board Meeting Outcome for Outcome Of Board Meeting

    30 May 2025, 4:25PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Dir
  • Titan Biotech Ltd. - Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financi

    26 May 2025, 12:24PM Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and ap
  • Titan Biotech Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    10 Apr 2025, 2:50PM As of March 2025, 55.87% is owned by Indian Promoters and 44.12% by Public. <p align=justify> Top five Promoters holding highest number of shares of T
  • Titan Biotech Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    5 Apr 2025, 4:14PM Compliance Certificate u/r 74(5) of SEBI(DP) Reg. 2018 for March 31, 2025
  • Titan Biotech Ltd. - Appointment Of Secretarial Auditor For The Financial Year Ended On 31/03/2025

    24 Mar 2025, 5:39PM Appointment of Secretarial Auditor for the financial year ended on 31/03/2025

Key fundamentals

Evaluate the intrinsic value of Titan Biotech Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 147.2358 135.613 113.0902 92.0429 73.3559
Liabilities 147.2358 135.613 113.0902 92.0429 73.3559
Equity 8.2637 8.2637 8.2637 8.2637 8.2637
Gross Profit 25.4264 34.2814 29.5192 31.1807 41.8054
Net Profit 18.2711 23.6632 21.0248 21.6843 28.7726
Cash From Operating Activities 20.1233 21.1463 21.1783 21.9524 17.7452
NPM(%) 11.67 14.42 14.6 17.55 23.49
Revenue 156.4508 164.0721 143.9993 123.5488 122.4593
Expenses 131.0244 129.7907 114.4801 92.3681 80.6538
ROE(%) 13.28 17.19 15.28 15.76 20.91

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Titan Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
GRM Overseas Ltd 337.05 6.04 33.62 2589.30 499.06 0.00
Jain Irrigation Systems Ltd 63.79 -1.66 133.00 29637.13 24.37 0.00
Tierra Agrotech Ltd 42.00 2.44 0.00 2413.76 -17.66 0.00
Kohinoor Foods Ltd 37.51 0.40 0.38 1599.82 983.91 0.00

Company Info

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Titan Medicares Ltd. (hereinafter referred to as "The Company" or TML) was incorporated as a public limited company on 18th February, 1992 under the Companies Act, 1956 and obtained the certificate of Commencement of Business on 25th February, 1992 from the Registrar of Companies Delhi & Haryana at New Delhi. 2007 - The Company has recently bagged export orders more than USD 130000 for export of its products. 2010 - Titan Biotech Ltd has recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share. 2014 - Titan Biotech Ltd has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each.

Read More

Parent Organisation

Titan Biotech Ltd.

Founded

18/02/1992

Managing Director

Mr.Naresh Kumar Singla

NSE Symbol

FAQ

The current price of Titan Biotech Ltd is

The 52-week high for Titan Biotech Ltd is

The market capitalization of Titan Biotech Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Titan Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Titan Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Titan Biotech Ltd shares.

The CEO of Titan Biotech Ltd is Mr.Naresh Kumar Singla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT